Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway

AimsAurora kinase A (AURKA) has been implicated in promoting myeloid and renal fibrosis. This study aimed to investigate the impact and underlying mechanism of AURKA on liver fibrosis and to assess the therapeutic potential of MLN8237, a small-molecule AURKA inhibitor, in preventing liver fibrosis i...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanqi Dai, Junhao Lin, Yuchuan Jiang, Xinhui Liu, Peng Chen, Yixiao Zhang, Zhenghui Song, Xuefen Zhuang, Jinge Cong, Yingchun Li, Xuanjia Hong, Yun Liu, Dong Xiao, Aimin Li, Yue Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1517226/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558769202364416
author Guanqi Dai
Guanqi Dai
Junhao Lin
Yuchuan Jiang
Yuchuan Jiang
Xinhui Liu
Peng Chen
Yixiao Zhang
Zhenghui Song
Xuefen Zhuang
Jinge Cong
Yingchun Li
Xuanjia Hong
Yun Liu
Dong Xiao
Dong Xiao
Aimin Li
Yue Luo
author_facet Guanqi Dai
Guanqi Dai
Junhao Lin
Yuchuan Jiang
Yuchuan Jiang
Xinhui Liu
Peng Chen
Yixiao Zhang
Zhenghui Song
Xuefen Zhuang
Jinge Cong
Yingchun Li
Xuanjia Hong
Yun Liu
Dong Xiao
Dong Xiao
Aimin Li
Yue Luo
author_sort Guanqi Dai
collection DOAJ
description AimsAurora kinase A (AURKA) has been implicated in promoting myeloid and renal fibrosis. This study aimed to investigate the impact and underlying mechanism of AURKA on liver fibrosis and to assess the therapeutic potential of MLN8237, a small-molecule AURKA inhibitor, in preventing liver fibrosis in mice.MethodsThe research used bioinformatics analysis and immunohistochemistry staining on fibrotic liver tissues from human and mouse models to assess AURKA expression. The cellular localization of AURKA was determined through double immunofluorescence staining in human fibrotic liver tissues and primary mouse hepatic stellate cells. RNA interference and AURKA antagonism were used to examine the effects of AURKA on liver fibrosis, while RNA-sequencing, qRT-PCR, and western blotting were employed to elucidate the potential molecular mechanisms of AURKA on hepatic stellate cell activation.ResultsThe results showed that AURKA was positively correlated with the progression of liver fibrosis and was predominantly expressed in activated HSCs. Silencing AURKA inhibited HSC activation and proliferation, and induced HSC apoptosis, effects that were similar to those observed with MLN8237 treatment. Additionally, silencing AURKA suppressed the glycogen synthase kinase-3β/β-catenin signaling pathway. Pharmacological inhibition of AURKA phosphorylation also resulted in reduced liver fibrosis in vivo.ConclusionIn conclusion, AURKA may promote HSC activation and liver fibrosis through the Wnt/β-catenin pathway, suggesting its potential as a therapeutic target for liver fibrosis.
format Article
id doaj-art-58610eaaa7c340e88cca949f9c99ad7e
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-58610eaaa7c340e88cca949f9c99ad7e2025-01-06T05:13:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.15172261517226Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathwayGuanqi Dai0Guanqi Dai1Junhao Lin2Yuchuan Jiang3Yuchuan Jiang4Xinhui Liu5Peng Chen6Yixiao Zhang7Zhenghui Song8Xuefen Zhuang9Jinge Cong10Yingchun Li11Xuanjia Hong12Yun Liu13Dong Xiao14Dong Xiao15Aimin Li16Yue Luo17Department of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaDepartment of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaDepartment of Endocrinology and Metabolic Diseases, Affiliated Hospital (Clinical College) of Xiangnan University, Chenzhou, ChinaCancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, ChinaLaboratory Animal Center, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaDepartment of Radiotherapy, Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medical University, Guangzhou, ChinaAimsAurora kinase A (AURKA) has been implicated in promoting myeloid and renal fibrosis. This study aimed to investigate the impact and underlying mechanism of AURKA on liver fibrosis and to assess the therapeutic potential of MLN8237, a small-molecule AURKA inhibitor, in preventing liver fibrosis in mice.MethodsThe research used bioinformatics analysis and immunohistochemistry staining on fibrotic liver tissues from human and mouse models to assess AURKA expression. The cellular localization of AURKA was determined through double immunofluorescence staining in human fibrotic liver tissues and primary mouse hepatic stellate cells. RNA interference and AURKA antagonism were used to examine the effects of AURKA on liver fibrosis, while RNA-sequencing, qRT-PCR, and western blotting were employed to elucidate the potential molecular mechanisms of AURKA on hepatic stellate cell activation.ResultsThe results showed that AURKA was positively correlated with the progression of liver fibrosis and was predominantly expressed in activated HSCs. Silencing AURKA inhibited HSC activation and proliferation, and induced HSC apoptosis, effects that were similar to those observed with MLN8237 treatment. Additionally, silencing AURKA suppressed the glycogen synthase kinase-3β/β-catenin signaling pathway. Pharmacological inhibition of AURKA phosphorylation also resulted in reduced liver fibrosis in vivo.ConclusionIn conclusion, AURKA may promote HSC activation and liver fibrosis through the Wnt/β-catenin pathway, suggesting its potential as a therapeutic target for liver fibrosis.https://www.frontiersin.org/articles/10.3389/fonc.2024.1517226/fullAurora kinase Ahepatic stellate cellsliver fibrosisMLN8237Wnt/β-catenin pathway
spellingShingle Guanqi Dai
Guanqi Dai
Junhao Lin
Yuchuan Jiang
Yuchuan Jiang
Xinhui Liu
Peng Chen
Yixiao Zhang
Zhenghui Song
Xuefen Zhuang
Jinge Cong
Yingchun Li
Xuanjia Hong
Yun Liu
Dong Xiao
Dong Xiao
Aimin Li
Yue Luo
Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
Frontiers in Oncology
Aurora kinase A
hepatic stellate cells
liver fibrosis
MLN8237
Wnt/β-catenin pathway
title Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
title_full Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
title_fullStr Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
title_full_unstemmed Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
title_short Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
title_sort aurora kinase a promotes hepatic stellate cell activation and liver fibrosis through the wnt β catenin pathway
topic Aurora kinase A
hepatic stellate cells
liver fibrosis
MLN8237
Wnt/β-catenin pathway
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1517226/full
work_keys_str_mv AT guanqidai aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT guanqidai aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT junhaolin aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yuchuanjiang aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yuchuanjiang aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT xinhuiliu aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT pengchen aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yixiaozhang aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT zhenghuisong aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT xuefenzhuang aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT jingecong aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yingchunli aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT xuanjiahong aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yunliu aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT dongxiao aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT dongxiao aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT aiminli aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway
AT yueluo aurorakinaseapromoteshepaticstellatecellactivationandliverfibrosisthroughthewntbcateninpathway